Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trialFlorian Lordick, Markus Moehler, Sang Cheul Oh et al.|The Lancet Oncology|2013Cited by 838
NEPTUNE: Phase 3 Study of First-Line Durvalumab Plus Tremelimumab in Patients With Metastatic NSCLCGilberto de Castro, Tony Mok, Naiyer A. Rizvi et al.|Journal of Thoracic Oncology|2022Cited by 72